Qube Research & Technologies LTD Inmune Bio, Inc. Transaction History

Qube Research & Technologies LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$7.15 - $11.84 $291,584 - $482,847	-40,781 Reduced 92.34%	3,384 $29,000
Q1 2024 May 14, 2024	BUY	$10.53 - $14.01 $155,085 - $206,339	14,728 Added 50.03%	44,165 $518,000
Q4 2023 Feb 13, 2024	BUY	$6.6 - $11.52 $194,284 - $339,114	29,437 New	29,437 $331,000
Q4 2020 Feb 16, 2021	SELL	$7.51 - $17.22 $180,097 - $412,952	-23,981 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$4.92 - $15.75 $117,986 - $377,700	23,981 New	23,981 $247,000

5.88M

243K

46.4K

Ticker INMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,946,000
Market Cap $89M
Description
INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient's innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on tr...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.